Patent · US Active

EPHA2 receptor antagonist antibodies

US8460667B2 · kind B2 · utility

5Cited by

54References

65Claims

0Family size

Assignee

Sanofi · FR

Inventors

Veronique Blanc · Paris, FR
Claudia Fromond · Paris, FR
Fabienne Parker · Saint-Maur-des-Fossés, FR
Jiawen Han · Paris, FR
Daniel Tavares · Natick, US
Chonghui Zhang · Brookline, US
Min Li · New Orleans, US
Xiao-Mai Zhou · Danbury, US
Michel Streuli · Brookline, US

Key dates

Filing date	Jul 13, 2007
Grant date	Jun 11, 2013
Priority date	—
Expiry date	Jun 1, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/91205
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antagonistic antibodies that specifically bind to and inhibit Class A Eph receptors are provided. Also provided are cytotoxic conjugates, pharmaceutical compositions and kits comprising these antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.